Is Multiple System Atrophy a Prion-like Disorder?


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Sep 2021
Historique:
received: 12 08 2021
revised: 16 09 2021
accepted: 16 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 20 11 2021
Statut: epublish

Résumé

Multiple system atrophy (MSA) is a rapidly progressive, fatal neurodegenerative disease of uncertain aetiology that belongs to the family of α-synucleinopathies. It clinically presents with parkinsonism, cerebellar, autonomic, and motor impairment in variable combinations. Pathological hallmarks are fibrillary α-synuclein (αSyn)-rich glial cytoplasmic inclusions (GCIs) mainly involving oligodendroglia and to a lesser extent neurons, inducing a multisystem neurodegeneration, glial activation, and widespread demyelinization. The neuronal αSyn pathology of MSA has molecular properties different from Lewy bodies in Parkinson's disease (PD), both of which could serve as a pool of αSyn (prion) seeds that could initiate and drive the pathogenesis of synucleinopathies. The molecular cascade leading to the "prion-like" transfer of "strains" of aggregated αSyn contributing to the progression of the disease is poorly understood, while some presented evidence that MSA is a prion disease. However, this hypothesis is difficult to reconcile with postmortem analysis of human brains and the fact that MSA-like pathology was induced by intracerebral inoculation of human MSA brain homogenates only in homozygous mutant 53T mice, without production of disease-specific GCIs, or with replication of MSA prions in primary astrocyte cultures from transgenic mice expressing human αSyn. Whereas recent intrastriatal injection of Lewy body-derived or synthetic human αSyn fibrils induced PD-like pathology including neuronal αSyn aggregates in macaques, no such transmission of αSyn pathology in non-human primates by MSA brain lysate has been reported until now. Given the similarities between αSyn and prions, there is a considerable debate whether they should be referred to as "prions", "prion-like", "prionoids", or something else. Here, the findings supporting the proposed nature of αSyn as a prion and its self-propagation through seeding as well as the transmissibility of neurodegenerative disorders are discussed. The proof of disease causation rests on the concordance of scientific evidence, none of which has provided convincing evidence for the classification of MSA as a prion disease or its human transmission until now.

Identifiants

pubmed: 34576255
pii: ijms221810093
doi: 10.3390/ijms221810093
pmc: PMC8472631
pii:
doi:

Substances chimiques

Prions 0
SNCA protein, human 0
alpha-Synuclein 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Neurol. 2019 May;85(5):691-703
pubmed: 30805957
Acta Neuropathol Commun. 2015 Nov 26;3:75
pubmed: 26612754
Exp Neurobiol. 2014 Dec;23(4):324-36
pubmed: 25548532
Cold Spring Harb Perspect Med. 2018 May 1;8(5):
pubmed: 28193770
Brain. 2019 Nov 1;142(11):3565-3579
pubmed: 31580415
Ann Indian Acad Neurol. 2016 Apr-Jun;19(2):169-74
pubmed: 27293325
Annu Rev Genet. 2013;47:601-23
pubmed: 24274755
Int J Mol Sci. 2017 Feb 22;18(2):
pubmed: 28241427
Ageing Res Rev. 2019 Mar;50:89-101
pubmed: 30690184
Acta Neuropathol Commun. 2021 May 3;9(1):80
pubmed: 33941284
J Alzheimers Dis. 2018;62(3):1141-1179
pubmed: 28984582
Mol Neurodegener. 2020 Mar 6;15(1):19
pubmed: 32143659
Brain Pathol. 2021 Sep;31(5):e12952
pubmed: 33754430
Nat Commun. 2021 Apr 14;12(1):2110
pubmed: 33854052
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5
pubmed: 19651612
Biol Aujourdhui. 2013;207(1):55-9
pubmed: 23694725
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Viruses. 2019 Mar 14;11(3):
pubmed: 30875755
Yakugaku Zasshi. 2019;139(7):1007-1013
pubmed: 31257247
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
J Neural Transm (Vienna). 2020 Jul;127(7):1031-1039
pubmed: 32367182
Trends Cell Biol. 2016 Jan;26(1):40-51
pubmed: 26455408
Ann Neurol. 2014 Mar;75(3):351-62
pubmed: 24243558
Acta Neuropathol. 2019 Oct;138(4):505-508
pubmed: 31407029
Acta Neuropathol. 2021 Jul;142(1):73-86
pubmed: 32440702
Neuropathol Appl Neurobiol. 2021 Aug;47(5):640-652
pubmed: 33368549
J Virol. 2017 Jan 3;91(2):
pubmed: 27852849
Trends Mol Med. 2020 Oct;26(10):936-952
pubmed: 32371172
Neuropathol Appl Neurobiol. 2021 Feb;47(2):268-282
pubmed: 32892415
CNS Neurol Disord Drug Targets. 2021 Apr 20;:
pubmed: 33881974
Mov Disord. 2020 May;35(5):756-757
pubmed: 32202672
Neuron. 2020 Jan 22;105(2):260-275.e6
pubmed: 31759806
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40
pubmed: 23690619
Cold Spring Harb Perspect Med. 2016 Sep 01;6(9):
pubmed: 27481772
J Neuropathol Exp Neurol. 2020 Nov 1;79(11):1141-1146
pubmed: 33000167
Neuroscientist. 2021 Aug;27(4):367-387
pubmed: 32729773
J Neural Transm (Vienna). 2021 Jul 28;:
pubmed: 34319460
Curr Opin Neurol. 2019 Apr;32(2):266-271
pubmed: 30724769
Cells. 2021 Feb 12;10(2):
pubmed: 33673034
Acta Neuropathol Commun. 2021 Aug 28;9(1):146
pubmed: 34454615
Science. 1996 Dec 20;274(5295):2079-82
pubmed: 8953038
Mov Disord. 2016 Feb;31(2):161-8
pubmed: 26347034
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):409-414
pubmed: 29279394
Nature. 2013 Sep 5;501(7465):45-51
pubmed: 24005412
Acta Neuropathol. 2021 Jul;142(1):87-115
pubmed: 33978813
Brain. 2017 Feb;140(2):266-278
pubmed: 27658420
Acta Neuropathol. 2002 May;103(5):516-20
pubmed: 11935269
Transl Neurodegener. 2021 Jun 21;10(1):20
pubmed: 34148543
Neuron. 2019 Aug 21;103(4):627-641.e7
pubmed: 31255487
Parkinsonism Relat Disord. 2016 Oct;31:87-90
pubmed: 27481034
Front Mol Neurosci. 2019 Nov 12;12:271
pubmed: 31780895
Acta Neuropathol. 2016 Jan;131(1):151-4
pubmed: 26541429
Science. 2012 Jun 22;336(6088):1511-3
pubmed: 22723400
Nature. 2009 Jun 18;459(7249):924-5
pubmed: 19536253
Cell Tissue Res. 2018 Jul;373(1):161-173
pubmed: 29480459
J Neurochem. 2016 Oct;139(2):162-180
pubmed: 27529376
Acta Neuropathol Commun. 2014 Jan 30;2:14
pubmed: 24479894
Neuropathol Appl Neurobiol. 2016 Feb;42(1):51-76
pubmed: 26666838
Parkinsonism Relat Disord. 2019 Oct;67:10-13
pubmed: 31621598
Transl Neurodegener. 2019 Sep 4;8:28
pubmed: 31508228
Acta Neuropathol Commun. 2019 May 20;7(1):80
pubmed: 31109378
Acta Neuropathol Commun. 2013 May 08;1:2
pubmed: 24252164
Annu Rev Microbiol. 2013;67:543-64
pubmed: 23808331
J Neural Transm (Vienna). 2005 Dec;112(12):1613-24
pubmed: 16284907
Neuron. 2014 Jun 18;82(6):1271-88
pubmed: 24857020
FEBS Open Bio. 2021 Apr;11(4):999-1013
pubmed: 33548114
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):
pubmed: 27920025
Acta Neuropathol. 2018 Jan;135(1):65-83
pubmed: 29209768
Neurobiol Aging. 2017 Jan;49:216.e15-216.e18
pubmed: 27793473
Viruses. 2019 Nov 09;11(11):
pubmed: 31717531
J Neurochem. 2017 Oct;143(1):126-135
pubmed: 28771723
J Theor Biol. 2020 Feb 7;486:110102
pubmed: 31809717
Neuron. 2002 May 16;34(4):521-33
pubmed: 12062037
Rev Neurol (Paris). 2018 Nov;174(9):644-652
pubmed: 30201422
Neurobiol Dis. 2018 Jan;109(Pt B):209-218
pubmed: 28751258
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4949-58
pubmed: 26286986
J Mov Disord. 2019 Sep;12(3):139-151
pubmed: 31556259
Lab Invest. 2019 Jul;99(7):971-981
pubmed: 30760864
Front Aging Neurosci. 2021 Jan 15;12:614587
pubmed: 33519421
Nat Rev Genet. 2018 Jul;19(7):405-418
pubmed: 29713012
Nat Rev Neurol. 2017 Apr;13(4):232-243
pubmed: 28303913
Acta Neuropathol. 2019 Oct;138(4):509-514
pubmed: 31407028
Neuropathol Appl Neurobiol. 2007 Dec;33(6):615-20
pubmed: 17990994
Lab Invest. 2019 Jul;99(7):982-992
pubmed: 30737468
Front Synaptic Neurosci. 2020 Sep 21;12:584536
pubmed: 33071772
Brain. 2019 Feb 1;142(2):228-230
pubmed: 30698762
Nat Med. 2008 May;14(5):501-3
pubmed: 18391963
Acta Neuropathol. 2020 Jan;139(1):3-25
pubmed: 31686182
Cell Tissue Res. 2018 Jul;373(1):213-220
pubmed: 29116402
PLoS Pathog. 2020 Feb 4;16(2):e1008222
pubmed: 32017806
J Biol Chem. 2020 Jul 24;295(30):10224-10244
pubmed: 32424039
Sci Rep. 2017 Aug 30;7(1):10050
pubmed: 28855681
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Neuropathol Appl Neurobiol. 2016 Feb;42(1):3-5
pubmed: 26819143
Mol Neurobiol. 2019 Nov;56(11):7448-7457
pubmed: 31041657
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5308-17
pubmed: 26324905
Nat Med. 2014 Feb;20(2):130-8
pubmed: 24504409
Neuropathol Appl Neurobiol. 2020 Oct;46(6):522-545
pubmed: 31868945
J Neurochem. 2016 Oct;139 Suppl 1:256-274
pubmed: 26924014
FASEB J. 2003 Oct;17(13):1945-7
pubmed: 14519670
Front Neurosci. 2019 Jun 18;13:552
pubmed: 31275093
Acta Neuropathol Commun. 2018 Apr 18;6(1):29
pubmed: 29669601
Acta Neuropathol. 2019 Oct;138(4):535-550
pubmed: 31254094
JAMA Neurol. 2013 Apr;70(4):462-8
pubmed: 23380910
Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):
pubmed: 28213437
Acta Neuropathol. 2021 Jul;142(1):5-16
pubmed: 33899132
J Neuropathol Exp Neurol. 2019 Oct 1;78(10):877-890
pubmed: 31504665
Front Mol Neurosci. 2019 Apr 25;12:107
pubmed: 31105524
Acta Neuropathol. 2021 Jul;142(1):1-3
pubmed: 33891174
Nature. 2016 Nov 09;539(7628):217-226
pubmed: 27830781
Methods Mol Biol. 2021;2322:27-39
pubmed: 34043189
Stem Cell Reports. 2018 Feb 13;10(2):356-365
pubmed: 29337114
J Biol Chem. 2019 Jan 18;294(3):1045-1058
pubmed: 30478174
Prog Mol Biol Transl Sci. 2019;168:323-348
pubmed: 31699325
Int J Mol Sci. 2021 May 08;22(9):
pubmed: 34066733
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10732-7
pubmed: 25002524
Lancet Neurol. 2017 Apr;16(4):323-332
pubmed: 28238712
Brain. 2015 Aug;138(Pt 8):2293-309
pubmed: 25981961
Mov Disord. 2018 Jul;33(7):1183-1184
pubmed: 29570847
Acta Neuropathol. 2019 Oct;138(4):515-533
pubmed: 31230104
Nature. 2004 Mar 18;428(6980):323-8
pubmed: 15029196
Nature. 2018 May;557(7706):558-563
pubmed: 29743672
Annu Rev Neurosci. 2015 Jul 8;38:87-103
pubmed: 25840008
Biomolecules. 2021 Feb 02;11(2):
pubmed: 33540845
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Mov Disord. 2021 Aug 27;:
pubmed: 34448510
Acta Neuropathol Commun. 2019 Jul 12;7(1):113
pubmed: 31300049
Nat Neurosci. 2019 Aug;22(8):1248-1257
pubmed: 31346295
Mov Disord. 2019 Mar;34(3):307-316
pubmed: 30653258
PLoS One. 2011;6(10):e26609
pubmed: 22039514
Ann Neurol. 2014 Mar;75(3):331-3
pubmed: 24615832
Acta Neuropathol. 2019 Mar;137(3):437-454
pubmed: 30690664
Prion. 2018 Jan 2;12(1):23-27
pubmed: 29308725
J Virol. 2016 Sep 29;90(20):9182-93
pubmed: 27489279
Biophys J. 2021 Mar 2;120(5):877-885
pubmed: 33515601
Pharmacol Ther. 2017 Apr;172:22-33
pubmed: 27916654
Nature. 2020 Feb;578(7794):273-277
pubmed: 32025029
Nature. 2016 Oct 26;538(7626):S13-S16
pubmed: 27783578
Acta Neuropathol Commun. 2017 Feb 2;5(1):12
pubmed: 28148299
Acta Neuropathol. 2019 Dec;138(6):913-941
pubmed: 31414210
Nat Neurosci. 2020 Jan;23(1):21-31
pubmed: 31792467
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):175-184
pubmed: 28860330
Int J Mol Sci. 2021 Aug 03;22(15):
pubmed: 34361100
Brain Pathol. 2013 May;23(3):342-9
pubmed: 23587140
Nature. 2020 Sep;585(7825):464-469
pubmed: 32461689
Curr Neurol Neurosci Rep. 2015 May;15(5):28
pubmed: 25868519
Science. 1982 Apr 9;216(4542):136-44
pubmed: 6801762
J Neurosci. 2017 Oct 11;37(41):9799-9807
pubmed: 29021297
Acta Neuropathol. 2019 Jul;138(1):23-47
pubmed: 30976973
Neurobiol Dis. 2018 May;113:1-10
pubmed: 29414379
Brain. 2013 Apr;136(Pt 4):1128-38
pubmed: 23466394
Acta Neuropathol Commun. 2014 Aug 06;2:88
pubmed: 25095794
Brain. 2019 Feb 1;142(2):249-254
pubmed: 30601948
Acta Neuropathol. 2020 Jun;139(6):977-1000
pubmed: 32356200
J Neurosci. 2017 Oct 11;37(41):9808-9818
pubmed: 29021298
Emerg Top Life Sci. 2020 Sep 8;4(2):155-167
pubmed: 32803268
Acta Neuropathol Commun. 2019 May 20;7(1):81
pubmed: 31109379
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19555-60
pubmed: 24218576
Cell Tissue Res. 2018 Jul;373(1):195-212
pubmed: 29704213
Mov Disord. 2019 Nov;34(11):1629-1642
pubmed: 31692132
Ann Neurol. 2018 Jan;83(1):10-12
pubmed: 29293269
Acta Neuropathol. 2016 Jan;131(1):49-73
pubmed: 26446103

Auteurs

Kurt A Jellinger (KA)

Institute of Clinical Neurobiology, 1150 Vienna, Austria.

Gregor K Wenning (GK)

Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Nadia Stefanova (N)

Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH